Determination of neutralizing antibodies against SARS-CoV-2

RS René Schramm
AC Angelika Costard-Jäckle
RR Rasmus Rivinius
BF Bastian Fischer
BM Benjamin Müller
UB Udo Boeken
AH Assad Haneya
ZP Zdenek Provaznik
CK Cornelius Knabbe
JG Jan Gummert
request Request a Protocol
ask Ask a question
Favorite

The presence of neutralizing antibodies against SARS-CoV-2 was determined using the cPass™ SARS-CoV-2 Neutralization Antibody Detection KIT (GenScript, Piscataway Township, USA) and performed according to the manufacturer’s instructions. The inhibition capability was calculated as follows:

According to the manufacturer, values greater than or equal to 20% were considered positive concerning neutralizing antibodies.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A